David Baltimore

Insider Reports History

Entity
Individual
Location
Amgen Inc., One Amgen Center Drive, Thousand Oaks, California
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Baltimore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Director Stock Option (Right to Buy) 60 K May 20, 2024 Direct

Insider Reports Filed by David Baltimore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. May 20, 2024 1 $0 4 May 21, 2024 Director
RGLS Regulus Therapeutics Inc. May 16, 2024 1 $0 4 May 17, 2024 Director
RGLS Regulus Therapeutics Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Director
RGLS Regulus Therapeutics Inc. Jun 13, 2023 1 $0 4 Jun 13, 2023 Director
RGLS Regulus Therapeutics Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
RGLS Regulus Therapeutics Inc. Jun 14, 2021 1 $0 4 Jun 15, 2021 Director